10 results
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
&D development committee (responsible for all R&D decisions from Phase 1 to approval), leading global business development (including delivering … on a deal for a promising immunotherapy), chairing significant global R&D alliances, and having responsibility for the launches of new medicines across
144
TYRA
Tyra Biosciences Inc
16 Jun 23
Notice of proposed sale of securities
4:42pm
+gkSC/x76XxAz1tMW/LYE22LpcFa9DP4grc9uHAuZBLWV6eDEKHyKo6iR
nMx39ycCbSIdhvRW7gImW10E869ADcIaHUs5VQdyEFYhf6IuHvgNOugnHVUHNQun9X8GfoU7
C/hnpbnAP+r+D/D7pNXgJ
144
TYRA
Tyra Biosciences Inc
16 Jun 23
Notice of proposed sale of securities
4:37pm
/x76XxAz1tMW/LYE22LpcFa9DP4grc9uHAuZBLWV6eDEKHyKo6iR
nMx39ycCbSIdhvRW7gImW10E869ADcIaHUs5VQdyEFYhf6IuHvgNOugnHVUHNQun9X8GfoU7
C/hnpbnAP+r+D/D7pNXgJ
144
8p67ouxr0 pa
16 Jun 23
Notice of proposed sale of securities
4:33pm
144
7k7btbb8
16 Jun 23
Notice of proposed sale of securities
4:25pm
144
z3j51nu3gp
16 Jun 23
Notice of proposed sale of securities
4:00pm
8-K
EX-99.1
4exitxzd5rg8tf 3ldz8
3 Nov 21
Tyra Biosciences Reports Third Quarter 2021 Financial Results and Highlights
4:16pm
- Prev
- 1
- Next